Articles

Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantation

Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany
Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany;Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Basel, Switzerland
Department of Hematology/Oncology, University Hospital Frankfurt, Germany
Department of Medicine I, Klinikum Bremen Mitte, Germany
Department of Medicine III, Klinikum Chemnitz GmbH, Chemnitz, Germany
Department of Hematology, Oncology, Pneumology, Universitätsmedizin der J Gutenberg-Universität, Mainz, Germany
Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany
III. Medizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, München, Germany
Department of Medicine III - Campus Grosshadern, University Hospital München, München, Germany
Department of Medicine III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany
Department of Medicine, University of Erlangen-Nürnberg Medical Center, Erlangen, Germany
Department of Medicine, Klinikum Frankfurt Höchst, Frankfurt, Germany
Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, Germany
Department of Medicine, Stiftungsklinikum Mittelrhein, Koblenz, Germany
Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany
Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany
Department of Hematology/Oncology, Freiburg University Medical Center, Freiburg, Germany
Vol. 98 No. 5 (2013): May, 2013 https://doi.org/10.3324/haematol.2012.076075